GLP1R and metabolic dysfunction-associated steatotic liver disease: The properties of GLP-1 RAs are particularly relevant for metabolic dysfunction–associated steatotic liver disease (MASLD), a leading comorbidity in people with HIV (PWH) characterized by excess intrahepatic triglyceride (IHTG) accumulation, insulin resistance, oxidative stress, and systemic inflammation7.